In our control experiments, VEGFR2 activation induced by CM from vehicle-treated hypoxic lung cancer cells was inhibited by a neutralizing antibody against VEGF as well as when CM from hypoxic lung cancer cells treated with VEGF-lowering JZL184 were used. This evidence concerns the gene VEGFA and lung cancer.